SACCHAROMYCES CEREVISIAE FUNGEMIA IN A HEAD AND NECK CANCER PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE
Acta Clinica Belgica2004Vol. 59(4), pp. 220–222
Citations Over TimeTop 14% of 2004 papers
Abstract
We report the case of a 65-year old male who developed Saccharomyces cerevisiae fungemia after completing a course of concomitant chemotherapy and radiation therapy for head and neck carcinoma. He had grade IV oral mucositis, and received Saccharomyces boulardii (Perenterol) orally as treatment for aseptic diarrhoea just before the onset of fungemia. We discuss the epidemiology and pathology of Saccharomyces cerevisiae in the cancer patient population.
Related Papers
- Assessment of Oral Mucositis among Patients Undergoing Radiotherapy for Head and Neck Cancer: An Audit.(2020)
- → Timing of Daily Radiotherapy for Cases of Head and Neck Cancer: Does It Make Difference?(2020)2 cited
- Treatment of Oral Mucositis during Radiotherapy for Head and Neck Cancer(2011)
- → EVALUATION OF LOW-INTENSITY LASER IN THE PREVENTION AND TREATMENT OF ORAL MUCOSITIS IN PATIENTS WITH HEAD AND NECK CANCER(2019)
- → Radiation induced mucositis and its relationship with nutritional status in head and neck cancer patients treated with radiotherapy(2019)